Eddie Power PhD MBA GFMD is the CEO of emPower Medical, a medical affairs consultancy empowering pharmaceutical medical professionals and solution providers to achieve their best potential. With over 25 years’ experience in the pharmaceutical industry, he is a recognized expert in Medical Affairs strategy, organizational design, storytelling, and innovation, and has been invited to chair and speak extensively at pharmaceutical congresses. He is an advisory board member for several organizations. He was formerly the VP, North America Medical Affairs, Hospital Business at Pfizer with the privilege of bringing one of the first Covid therapies to the world and has held positions of increasing responsibility during his 25 year career in the pharmaceutical industry, with deep expertise in medical affairs and medicines & device development.

Ana Bozas is currently Director of Scientific Publications and Medical Communications at Ipsen Biopharmaceuticals, Inc, in Boston, MA. Ana is a Certified Medical Publication Professional (CMPP) and holds a PhD in in biochemistry from the University of Utah. Over the past decade, Ana has held positions with increasing responsibilities, starting from HEOR medical writer in management consulting to leading medical communications planning and strategy in several biotech/pharmaceuticals/medical device companies. During her career, Ana has covered a wide range of scientific communication activities across multiple disease areas, with products marketed in the US and world-wide.

Matt oversees the Artificial and Augmented Intelligence function across Inizio Medical, aligned to the Medical Analytics and Innovation department which he Founded and has led to its position of market leadership since 2016. With 25 years of life sciences experience, Matt specializes in partnering with key stakeholders to speed time to decision leveraging artificial intelligence, advanced analytics, digital innovation and bespoke consultancy. He has deep expertise in oncology/hematology, neuropsychiatry and rare disorders and has contributed to the launch of over 60 treatments globally. Matt Co-Chairs the AI Task Force at the International Society for Medical Publication Professionals, where he oversaw the development and publication of the global roadmap and call to action on Artificial Intelligence, published on November 1st, co-authored the Declarative Statement on Artificial Intelligence for the Healthcare Communications Association, published in early October, was the featured speaker in 2023 for the Medical Affairs Professional Society Executive Consortium, on Augmented Intelligence, and helped to architect its Generative AI White Paper, published on September 28, 2023, is a founding Board Member of the Society for Artificial Intelligence and Health, and is the Executive Lead for Inizio Medical’s Business Employee Resource Group on Mental Health and Wellbeing. He is a frequently requested Keynote Speaker on Artificial Intelligence, Medical Affairs and Mental Wellness. Prior to his role at Inizio Medical, Matt led Strategy and Account Planning at Omnicom Health Group, WPP and worked at both Boehringer Ingelheim as a Senior Scientist and at Procter and Gamble Pharmaceuticals as both a Medical Science Liaison and a Regional Scientific Manager. He has his Masters degree in Health Services Research from New York University and his Bachelors, cum laude, from Cornell University in Molecular and Cellular Biology, with a concentration in Management and Marketing. He has done post-graduate work at Columbia University in Adult Learning and Health Psychology and at INSEAD in Corporate Strategy and Digital Health Strategy. He resides in Westchester County, New York, with his wife who is a Director at Memorial Sloan Kettering Cancer Center and his two daughters, 14 and 9, and cavapoo puppy.

Gigi Shafai, Pharm.D., is Vice President of Medical Affairs & Digital Transformation at TransPerfect Life Sciences, where she connects dots across people, process, technology culture, and language to advance innovation for human health experiences. Gigi has over 18 years of experience in the life science industry, having worked across therapeutic areas and departments at leading companies. Leveraging her diverse multidisciplinary biopharma and pharmacy background, she has worked in highly matrixed cross-functional settings during business transformation periods and through corporate alliances. She believes in the technological advances that now allow a transformation the way we connect and communicate scientific information and insights in meaningful ways to various audiences and across language and culture. Her experiences from clinical through commercialization brings an integrative cross-functional perspective for R&D and commercialization teams. Gigi has published and presented at scientific conferences, contributed to research design and analysis, supported brand teams and advanced corporate strategy.

Kurt is a distinguished generative AI leader in pharmaceutical digital marketing and digital medical communications, with over 20 years of experience. He holds advanced AI in Healthcare and Generative AI Prompt Engineering certifications from prestigious universities. As a thought leader in the industry, Kurt frequently publishes articles in leading industry publications and is a speaker at prominent conferences. The Bracken Group supports the growth of life science firms. We enable clients to conduct business with broader capabilities, deeper expertise, better processes, and more data than they had before – from ad hoc consulting to regulatory, marketing, data analytics, and C suite services.

Matt oversees the Artificial and Augmented Intelligence function across Inizio Medical, aligned to the Medical Analytics and Innovation department which he Founded and has led to its position of market leadership since 2016. With 25 years of life sciences experience, Matt specializes in partnering with key stakeholders to speed time to decision leveraging artificial intelligence, advanced analytics, digital innovation and bespoke consultancy. He has deep expertise in oncology/hematology, neuropsychiatry and rare disorders and has contributed to the launch of over 60 treatments globally. Matt Co-Chairs the AI Task Force at the International Society for Medical Publication Professionals, where he oversaw the development and publication of the global roadmap and call to action on Artificial Intelligence, published on November 1st, co-authored the Declarative Statement on Artificial Intelligence for the Healthcare Communications Association, published in early October, was the featured speaker in 2023 for the Medical Affairs Professional Society Executive Consortium, on Augmented Intelligence, and helped to architect its Generative AI White Paper, published on September 28, 2023, is a founding Board Member of the Society for Artificial Intelligence and Health, and is the Executive Lead for Inizio Medical’s Business Employee Resource Group on Mental Health and Wellbeing. He is a frequently requested Keynote Speaker on Artificial Intelligence, Medical Affairs and Mental Wellness. Prior to his role at Inizio Medical, Matt led Strategy and Account Planning at Omnicom Health Group, WPP and worked at both Boehringer Ingelheim as a Senior Scientist and at Procter and Gamble Pharmaceuticals as both a Medical Science Liaison and a Regional Scientific Manager. He has his Masters degree in Health Services Research from New York University and his Bachelors, cum laude, from Cornell University in Molecular and Cellular Biology, with a concentration in Management and Marketing. He has done post-graduate work at Columbia University in Adult Learning and Health Psychology and at INSEAD in Corporate Strategy and Digital Health Strategy. He resides in Westchester County, New York, with his wife who is a Director at Memorial Sloan Kettering Cancer Center and his two daughters, 14 and 9, and cavapoo puppy.

Barbara Salami is a seasoned leader with over 20 years of experience in marketing, commercial operations, data and analytics, technology, customer experience, and digital transformation. As the US Head of Commercial Excellence and Innovation at Novo Nordisk, she drives key strategic initiatives including AI adoption, customer experience and marketing excellence . Formerly the Global VP of Commercial Digital Technology at Moderna, Barbara envisioned and built a cutting-edge digital ecosystem powering global operations across 17 countries. Celebrated for her authentic and collaborative leadership, she also mentors young talents and serves on advisory boards for healthcare start-ups. Barbara holds an MBA from Penn State and a BS in Biomedical Engineering from Drexel University.

Sara Green has directed health and medical content with a strong consumer lens for over a decade. She serves as senior director of content strategy for all media for WebMD Ignite, including digital, video, animation, print, AI, and interactive. In addition to prior roles directing and developing content at Rodale and Remedy Health media, she taught nonfiction writing at Columbia University, where she served as Editor-in-Chief of the Columbia Journal.

Health and medical content Sara strategized, edited, and produced has been nominated for and won multiple awards including National Magazine Awards, Digital Health Awards, and a James Beard Award.

Sasha is a patient-forward leader with extensive industry experience and proven track-record across US commercial and Global R&D roles leading innovation in Gene Therapy, Rare Disease, Blood Disorders and Neuroscience. Currently at AstraZeneca, Sasha is leading the launch of Baxdrostat, a novel mechanism in the treatment of hypertension, including Omnichannel and AI innovation.

Dana Weber specializes in performance marketing, and has led digital marketing solutions for some of the world’s most notable brands including Amazon, JnJ, AMEX, Adobe, LVMH, and many more. Dana leads the TransPerfect Digital Client Services team and knows how to help clients generate business outcomes in any market or language, with a data-led ROI mindset.

Matt oversees the Artificial and Augmented Intelligence function across Inizio Medical, aligned to the Medical Analytics and Innovation department which he Founded and has led to its position of market leadership since 2016. With 25 years of life sciences experience, Matt specializes in partnering with key stakeholders to speed time to decision leveraging artificial intelligence, advanced analytics, digital innovation and bespoke consultancy. He has deep expertise in oncology/hematology, neuropsychiatry and rare disorders and has contributed to the launch of over 60 treatments globally. Matt Co-Chairs the AI Task Force at the International Society for Medical Publication Professionals, where he oversaw the development and publication of the global roadmap and call to action on Artificial Intelligence, published on November 1st, co-authored the Declarative Statement on Artificial Intelligence for the Healthcare Communications Association, published in early October, was the featured speaker in 2023 for the Medical Affairs Professional Society Executive Consortium, on Augmented Intelligence, and helped to architect its Generative AI White Paper, published on September 28, 2023, is a founding Board Member of the Society for Artificial Intelligence and Health, and is the Executive Lead for Inizio Medical’s Business Employee Resource Group on Mental Health and Wellbeing. He is a frequently requested Keynote Speaker on Artificial Intelligence, Medical Affairs and Mental Wellness. Prior to his role at Inizio Medical, Matt led Strategy and Account Planning at Omnicom Health Group, WPP and worked at both Boehringer Ingelheim as a Senior Scientist and at Procter and Gamble Pharmaceuticals as both a Medical Science Liaison and a Regional Scientific Manager. He has his Masters degree in Health Services Research from New York University and his Bachelors, cum laude, from Cornell University in Molecular and Cellular Biology, with a concentration in Management and Marketing. He has done post-graduate work at Columbia University in Adult Learning and Health Psychology and at INSEAD in Corporate Strategy and Digital Health Strategy. He resides in Westchester County, New York, with his wife who is a Director at Memorial Sloan Kettering Cancer Center and his two daughters, 14 and 9, and cavapoo puppy.

Amanda Hernandez is a seasoned professional with a unique blend of clinical expertise and extensive experience in sales and leadership. With a foundational background as a Registered Nurse, Amanda transitioned into the business world where she has excelled in sales, training, and development roles for over two decades. Currently, Amanda serves as the Director of Sales Training and Effectiveness at Telix Pharmaceuticals, where she is instrumental in shaping the sales strategy and driving performance excellence. Her role involves leading initiatives that enhance the effectiveness of the sales team, developing impactful training programs, and fostering an environment that supports ongoing professional growth. Amanda’s career is marked by her success as a sales representative and her subsequent leadership roles. She has a proven track record of not only meeting but exceeding sales targets, and her passion for helping others succeed is evident in her approach to training and development. Her unique combination of skills allows her to bridge the gap between clinical knowledge and business acumen, delivering exceptional results and empowering teams to achieve their full potential. With a deep commitment to professional development and a drive for continuous improvement, Amanda remains dedicated to advancing her field and contributing to the success of Telix Pharmaceuticals. Telix is a commercial-stage biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic (‘theranostic’) radiopharmaceuticals.

Bob Holliday is the Senior Director, Training & Medical Education for Cytovale. He has over 30 years of Learning & Leadership development experience across life sciences organizations and the US Air Force; working in startups to very large organizations, both with US and global responsibilities. He holds a BS in Organizational Management and a MBA in Strategic Human Resource Management Cytovale is a medical diagnostics company that uses machine learning technology to help diagnose fast-moving diseases. Its IntelliSep test stratifies the risk of a patient developing sepsis upon presenting at an Emergency department.

Jessica Peyser is a Sr. Sales Director at TransPerfect Life Sciences supporting pharmaceutical, biotech and medical device companies. Jessica joined TransPerfect’s sales team in 2014, and has progressed from an individual contributor to senior management position, manging dozens of client relationships. She has a passion for solving tough problems and building personal relationships with everyone she works with. Most importantly, she loves the positive impact her work has on bringing therapies to patients, herself a rare disease survivor.

Ella Balasa is a patient advocate, consultant, and a person living with cystic fibrosis. She has committed her time to empowering patients and advancing healthcare strategies. She speaks publicly about the value of patient perspective and has a passion for distilling clinical information for patient communities. Through opportunities working with healthcare organizations on content strategy, writing, speaking, clinical trial development, and sharing the patient experience, she aims to affect the healthcare landscape by raising awareness of rare diseases, promoting self-advocacy to patients, and valuable insights to organizations. More of her work and experiences can be found at www.ellabalasa.com.

Kristin is the Co-Founder and CEO of the Curing Retinal Blindness Foundation, the only patient organization for CRB1 LCA/RP, the rare eye disease that caused her sons’ blindness. The foundation has raised over $4 million and achieved the first-ever National Rare Eye Disease Awareness Day, with legislation submitted in Braille. Kristin partnered with Spark Therapeutics to help achieve the first FDA-approved gene therapy for retinal disease. She authored the bestselling Thriving Blind and the award-winning children’s book What I Can Be Is Up to Me and co-created the film The Greatest Equalizer.

Matt Holms is the VP of Sales responsible for overseeing Patient Engagement & Recruitment Solutions at Citeline. He has spent 24 years in the Life Science industry, holding various commercial & executive leadership roles, dedicated to driving innovative technology solutions that enhance clinical research across a diverse spectrum of eClinical technology, Patient Recruitment/RWD, and Sponsor organizations. Beyond his professional endeavors, he is passionate about patient access and awareness of clinical research opportunities, having personally experienced life-changing results and benefits as a clinical research study participant.

Joseph Kim has over 25 years of experience in clinical research from companies like, Merck, Shire and Lilly. He serves as the Chief Strategy Officer of ProotPilot – and award winning platform digitalizing the end-to-end experience for patients and sites.

Leanne Woehlke is the Executive Vice President at Soglia, a division of Entrada. As a Patient Experience Organization, or PXO, Entrada is driven to reimagine the way patients interact with pharmaceutical companies throughout their treatment journey. With extensive experience in clinical research, along with knowledge of digital marketing and coaching, Leanne brings a unique perspective to patient recruitment and engagement. Always passionate about impacting the industry in meaningful ways and bringing life-changing treatments to patients who need them, Leanne, is committed to helping patients feel more in control of their health journey.